Stocks to watch:

Array Biopharma CEO: Developing products ourselves

Now watching

Next video starts in : 7 Play

Array Biopharma CEO: Developing products ourselves

Array Biopharma CEO: Developing products ourselves
Replay video
Up next

Who wants to smoke Cubans?

Unlock your personal NFL Now stream by signing in to NFL.com

Array Biopharma CEO: Developing products ourselves

by CNBC Videos 6:59 mins

Mad Money host Jim Cramer calls Array BioPharma a spec play. The company has 6 trials in phase 3 in progress. Its CEO Ron Squarer discusses its partnerships with big players including Novartis and Celgene.

View Comments (0)